| From PCP to MXE: a comprehensive review of the non‐medical use of dissociative drugs H Morris, J Wallach Drug testing and analysis 6 (7-8), 614-632, 2014 | 285 | 2014 |
| Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species AL Halberstadt, M Chatha, AK Klein, J Wallach, SD Brandt Neuropharmacology 167, 107933, 2020 | 203 | 2020 |
| Endogenous hallucinogens as ligands of the trace amine receptors: a possible role in sensory perception JV Wallach Medical hypotheses 72 (1), 91-94, 2009 | 91 | 2009 |
| Return of the lysergamides. Part I: Analytical and behavioural characterization of 1‐propionyl‐d‐lysergic acid diethylamide (1P‐LSD) SD Brandt, PV Kavanagh, F Westphal, A Stratford, SP Elliott, K Hoang, ... Drug testing and analysis 8 (9), 891-902, 2016 | 88 | 2016 |
| Pharmacological investigations of the dissociative ‘legal highs’ diphenidine, methoxphenidine and analogues J Wallach, H Kang, T Colestock, H Morris, ZA Bortolotto, GL Collingridge, ... PLoS One 11 (6), e0157021, 2016 | 79 | 2016 |
| Return of the lysergamides. Part II: Analytical and behavioural characterization of N6‐allyl‐6‐norlysergic acid diethylamide (AL‐LAD) and (2’S,4’S)‐lysergic acid … SD Brandt, PV Kavanagh, F Westphal, SP Elliott, J Wallach, T Colestock, ... Drug testing and analysis 9 (1), 38-50, 2017 | 68 | 2017 |
| Return of the lysergamides. Part III: Analytical characterization of N6‐ethyl‐6‐norlysergic acid diethylamide (ETH‐LAD) and 1‐propionyl ETH‐LAD (1P–ETH‐LAD) SD Brandt, PV Kavanagh, F Westphal, SP Elliott, J Wallach, A Stratford, ... Drug testing and analysis 9 (10), 1641-1649, 2017 | 67 | 2017 |
| First reported fatalities associated with the ‘research chemical’2-methoxydiphenidine SP Elliott, SD Brandt, J Wallach, H Morris, PV Kavanagh Journal of Analytical Toxicology 39 (4), 287-293, 2015 | 63 | 2015 |
| Return of the lysergamides. Part IV: analytical and pharmacological characterization of lysergic acid morpholide (LSM‐775) SD Brandt, PV Kavanagh, B Twamley, F Westphal, SP Elliott, J Wallach, ... Drug testing and analysis 10 (2), 310-322, 2018 | 54 | 2018 |
| Identification of 5-HT2A receptor signaling pathways associated with psychedelic potential J Wallach, AB Cao, MM Calkins, AJ Heim, JK Lanham, EM Bonniwell, ... Nature Communications 14 (1), 8221, 2023 | 52 | 2023 |
| Pharmaceutical chemistry A Abelian, M Dybek, J Wallach, B Gaye, A Adejare Remington, 105-128, 2021 | 47 | 2021 |
| 1, 2-Diarylethylamine-and ketamine-based new psychoactive substances J Wallach, SD Brandt New Psychoactive Substances: Pharmacology, Clinical, Forensic and Analytical …, 2018 | 47 | 2018 |
| Test purchase, synthesis, and characterization of 2‐methoxydiphenidine (MXP) and differentiation from its meta‐ and para‐substituted isomers G McLaughlin, N Morris, PV Kavanagh, JD Power, J O'Brien, B Talbot, ... Drug Testing and Analysis 8 (1), 98-109, 2016 | 42 | 2016 |
| Return of the lysergamides. Part V: Analytical and behavioural characterization of 1‐butanoyl‐d‐lysergic acid diethylamide (1B‐LSD) SD Brandt, PV Kavanagh, F Westphal, A Stratford, SP Elliott, G Dowling, ... Drug testing and analysis 11 (8), 1122-1133, 2019 | 41 | 2019 |
| New psychoactive substances 3-methoxyphencyclidine (3-MeO-PCP) and 3-methoxyrolicyclidine (3-MeO-PCPy): metabolic fate elucidated with rat urine and human liver preparations … J A A Michely, S K Manier, A T Caspar, S D Brandt, J Wallach, H H Maurer Current Neuropharmacology 15 (5), 692-712, 2017 | 41 | 2017 |
| Ephenidine: A new psychoactive agent with ketamine-like NMDA receptor antagonist properties H Kang, P Park, ZA Bortolotto, SD Brandt, T Colestock, J Wallach, ... Neuropharmacology 112, 144-149, 2017 | 41 | 2017 |
| Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA) AL Halberstadt, LM Klein, M Chatha, LB Valenzuela, A Stratford, ... Psychopharmacology 236, 799-808, 2019 | 39 | 2019 |
| Phencyclidine-based new psychoactive substances J Wallach, SD Brandt New Psychoactive Substances: Pharmacology, Clinical, Forensic and Analytical …, 2018 | 38 | 2018 |
| Preparation and characterization of the ‘research chemical’diphenidine, its pyrrolidine analogue, and their 2, 2‐diphenylethyl isomers J Wallach, PV Kavanagh, G McLaughlin, N Morris, JD Power, SP Elliott, ... Drug Testing and Analysis 7 (5), 358-367, 2015 | 35 | 2015 |
| Return of the lysergamides. Part VI: Analytical and behavioural characterization of 1‐cyclopropanoyl‐d‐lysergic acid diethylamide (1CP‐LSD) SD Brandt, PV Kavanagh, F Westphal, A Stratford, AU Odland, AK Klein, ... Drug testing and analysis 12 (6), 812-826, 2020 | 33 | 2020 |
